The store will not work correctly when cookies are disabled.
1-(3-(4-(2,4-dihydroxyphenyl)thiazol-2-ylamino)phenyl)ethanone
ID: ALA3618483
PubChem CID: 1075902
Max Phase: Preclinical
Molecular Formula: C17H14N2O3S
Molecular Weight: 326.38
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(=O)c1cccc(Nc2nc(-c3ccc(O)cc3O)cs2)c1
Standard InChI: InChI=1S/C17H14N2O3S/c1-10(20)11-3-2-4-12(7-11)18-17-19-15(9-23-17)14-6-5-13(21)8-16(14)22/h2-9,21-22H,1H3,(H,18,19)
Standard InChI Key: BSPURTJDKZTSBI-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5972 -1.5031 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.5951 -3.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8056 -3.8680 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-3.3371 -5.2929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8371 -5.2877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3786 -3.8595 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.9508 -6.4988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4503 -7.9079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4759 -9.0482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9989 -8.7745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4993 -7.3604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5248 -6.2201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6302 -8.1265 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.7785 -9.6868 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5973 -1.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5956 -2.7031 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6375 -0.9049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 8 2 0
11 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
14 19 1 0
16 20 1 0
1 21 1 0
21 22 2 0
21 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 326.38 | Molecular Weight (Monoisotopic): 326.0725 | AlogP: 4.17 | #Rotatable Bonds: 4 |
Polar Surface Area: 82.45 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.48 | CX Basic pKa: 2.02 | CX LogP: 3.74 | CX LogD: 3.71 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.63 | Np Likeness Score: -1.07 |
References
1. Al-Asri J, Fazekas E, Lehoczki G, Perdih A, Görick C, Melzig MF, Gyémánt G, Wolber G, Mortier J.. (2015) From carbohydrates to drug-like fragments: Rational development of novel α-amylase inhibitors., 23 (20): [PMID:26395057] [10.1016/j.bmc.2015.09.007] |